NanoViricides - 53 Year Dividend History | NNVC

Historical dividend payout and yield for NanoViricides (NNVC) since 1971. The current TTM dividend payout for NanoViricides (NNVC) as of April 25, 2024 is $0.00. The current dividend yield for NanoViricides as of April 25, 2024 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.013B $0.000B
NanoViricides, Inc. is a development stage company focused on creating special purpose nanomaterials for antiviral therapy. The Company's novel nanoviricide class of drug candidates are designed to specifically attack enveloped virus particles and to dismantle them. It also focuses on the development of drugs against a number of viral diseases including H1N1 swine flu, H5N1 bird flu, seasonal Influenza, HIV, oral and genital Herpes, viral diseases of the eye including EKC and herpes keratitis, Hepatitis C, Rabies, Dengue fever, and Ebola virus, among others. NanoViricides, Inc. is headquartered in West Haven, Connecticut.
Stock Name Country Market Cap PE Ratio